Daniel M. Byrd, MD Providence Medical Group

Languages: English
Professional Statement
Dr. Byrd is a Hematologist/Oncologist specializing in Providence Regional Cancer System.
Education
Institution
Type
University of Texas Southwestern Medical School at Dallas
Medical School
Oregon Health Science University, Portland
Internship
Oregon Health Sciences University, Portland
Residency
Oregon Health Science University, Portland
Fellowship
Board Certifications
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Hematology
Clinical Interests
  • sweat gland carcinoma
  • adverse effects to anticoagulants
  • amyloidosis
  • anemia
  • antithrombin deficiency
  • b12 deficiency anemia
  • bladder cancer genomics
  • blood cancer
  • blood disorders
  • bone marrow disorders
  • brain cancer genomics
  • breast cancer genomics
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer genomics
  • cancer pain
  • cancer risk assessment
  • cancer survivorship
  • cancer-related fatigue
  • cervical cancer genomics
  • chemoradiation
  • colon cancer genomics
  • cowden syndrome
  • crizotinib
  • egfr mutation
  • egfr translocation
  • endocrine complications of cancer therapy
  • endometrial cancer genomics
  • erlotinib
  • factor v leiden
  • gallbladder cancer genomics
  • gastrointestinal cancer genomics
  • genitourinary cancer genomics
  • gynecologic cancer genomics
  • head and neck cancer care
  • head and neck cancer genomics
  • hellp syndrome
  • hemochromatosis
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • hypogammaglobulinemia
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • langerhans cell histiocytosis
  • leukemia genomics
  • leukocytosis
  • leukopenia
  • liver cancer genomics
  • lung cancer genomics
  • lymphoma genomics
  • lymphopenia
  • maternal hematologic disorders
  • melanoma genomics
  • monoclonal gammopathy of undetermined significance
  • musculoskeletal tumor
  • myelodysplasia
  • myelodysplastic syndrome
  • myeloproliferative diseases
  • neutropenia
  • non hodgkins lymphoma
  • oral complications of cancer
  • pancreatic cancer genomics
  • pancytopenia
  • paroxysmal nocturnal hemoglobinuria
  • petechiae
  • peutz-jeghers syndrome
  • plasma cell dyscrasia
  • polycythemia
  • prostate cancer genomics
  • pulmonary metastases
  • purpura
  • radionuclide therapy
  • rectal cancer genomics
  • renal cancer genomics
  • retroperitoneal mass
  • rh incompatibility
  • sarcoma genomics
  • secondary polycythemia
  • side effects of cancer treatment
  • skin cancer genomics
  • splenomegaly
  • stomach cancer genomics
  • submucosal tumors
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • thyroid cancer genomics
  • tracheal cancer
  • unknown primary cancer
PATIENT RATINGS AND COMMENTS

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.8 out of 5 (94 Ratings, 0 Comments)


1821112293
 
Providence Regional Cancer System - Lacey
4525 3rd Avenue Southeast Suite 200
Lacey, WA 98503
360-943-8023
Providence Regional Cancer System - Centralia
2015 Cooks Hill Road Suite 200
Centralia, WA 98531
360-330-8916
Affiliated Facilities
Providence St. Peter Hospital
Providence Centralia Hospital